VCM
CORT icon

Versant Capital Management’s Corcept Therapeutics CORT Stock Holding History

Versant Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.7K Buy
206
+34
+20% +$3.66K ﹤0.01% 1861
2026
Q2 		$15K Buy
172
+145
+537% +$8.76K ﹤0.01% 2076
2026
Q1 		$1.09K Sell
27
-7
-21% -$262 ﹤0.01% 2643
2025
Q4 		$1.18K Buy
34
+7
+26% +$550 ﹤0.01% 2514
2025
Q3 		$2.24K Hold
27
– – ﹤0.01% 2390
2025
Q2 		$1.98K Hold
27
– – ﹤0.01% 2383
2025
Q1 		$3.08K Hold
27
– – ﹤0.01% 2190
2024
Q4 		$1.36K Hold
27
– – ﹤0.01% 2130
2024
Q3 		$1.25K Hold
27
– – ﹤0.01% 1694
2024
Q2 		$877 Hold
27
– – ﹤0.01% 1703
2024
Q1 		$680 Sell
27
-22
-45% -$520 ﹤0.01% 1632
2023
Q4 		$1.59K Sell
49
-57
-54% -$1.56K ﹤0.01% 1366
2023
Q3 		$2.89K Hold
106
– – ﹤0.01% 1177
2023
Q2 		$2.36K Buy
106
+22
+26% +$506 ﹤0.01% 1312
2023
Q1 		$1.82K Hold
84
– – ﹤0.01% 1296
2022
Q4 		$1.71K Sell
84
-13
-13% -$326 ﹤0.01% 1178
2022
Q3 		$2K Buy
97
+9
+10% +$241 ﹤0.01% 1058
2022
Q2 		$2K Hold
88
– – ﹤0.01% 1076
2022
Q1 		$2K Buy
88
+70
+389% +$1.49K ﹤0.01% 1113
2021
Q4 		$0 Hold
18
– – ﹤0.01% 1458
2021
Q3 		$0 Hold
18
– – ﹤0.01% 1468
2021
Q2 		$0 Hold
18
– – ﹤0.01% 1467
2021
Q1 		$0 Hold
18
– – ﹤0.01% 1532
2020
Q4 		$0 Hold
18
– – ﹤0.01% 1363
2020
Q3 		$0 Hold
18
– – ﹤0.01% 1325
2020
Q2 		$0 Hold
18
– – ﹤0.01% 1330
2020
Q1 		$0 Buy
+18
New +$223 ﹤0.01% 1361

Other funds holding CORT

VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Versant Capital Management's CORT Position: Q3 2026 in Review

Versant Capital Management increased its Corcept Therapeutics (CORT) stake by 20% in Q3 2026, buying an estimated $3.66K and bringing the position to 206 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Versant Capital Management first reported a position in CORT in Q1 2020 and has held it in 27 quarters since. 12 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Versant Capital Management held 206 shares of Corcept Therapeutics worth $23.7K as of Q3 2026.
  • Versant Capital Management bought 34 Corcept Therapeutics shares in Q3 2026, an estimated $3.66K.
  • Corcept Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1861 holding.
  • Versant Capital Management first reported a position in Corcept Therapeutics in Q1 2020 and has held it in 27 quarters since.
  • 12 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.